Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi in Talks About $80-a-Share Deal for Genzyme, WSJ Reports
Sanofi in Talks About $80-a-Share Deal for Genzyme, WSJ Reports
Sanofi in Talks About $80-a-Share Deal for Genzyme, WSJ Reports
Submitted by
admin
on January 8, 2011 - 11:51am
Source:
Bloomberg
News Tags:
Sanofi
Genzyme
Headline:
Sanofi in Talks About $80-a-Share Deal for Genzyme, WSJ Reports
Do Not Allow Advertisers to Use My Personal information
